US Stock MarketDetailed Quotes

HOWL Werewolf Therapeutics

Watchlist
  • 0.972
  • -0.058-5.61%
Close Mar 31 16:00 ET
  • 0.960
  • -0.012-1.25%
Pre 09:20 ET
43.58MMarket Cap-0.60P/E (TTM)

About Werewolf Therapeutics Company

Werewolf Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer. The firm offers Predator Technology which focuses on immune targeting and activation. The company was founded by Daniel J. Hicklin, Patrick A. Baeuerle, and Luke B. Evnin on October 19, 2017 and is headquartered in Watertown, MA.

Company Profile

SymbolHOWL
Company NameWerewolf Therapeutics
Listing DateApr 30, 2021
Issue Price16.00
Founded2017
CEODr. Daniel J. Hicklin,, PhD
MarketNASDAQ
Employees46
Fiscal Year Ends12-31
Address200 Talcott Avenue,2nd floor
CityWatertown
ProvinceMassachusetts
CountryUnited States of America
Zip Code02472
Phone1-617-952-0555

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Daniel J. Hicklin,, PhD
  • Director, President and Chief Executive Officer
  • 1.37M
  • Ellen Lubman, M.B.A.
  • Chief Business Officer
  • --
  • Dr. Randi Isaacs, M.D.
  • Chief Medical Officer
  • 855.77K
  • Dr. Chulani Karunatilake, PhD
  • Chief Technology Officer
  • --
  • Timothy W. Trost
  • Chief Financial Officer, Principal Accounting Officer and Treasurer
  • 815.59K
  • Dr. Luke B. Evnin,PhD
  • Chairman of the Board
  • 104.03K
  • Dr. Anil K. Singhal, PhD
  • Director
  • --
  • Dr. Michael B. Atkins, M.D.
  • Director
  • --
  • Dr. Briggs W. Morrison, M.D.
  • Director
  • 62.32K
  • Dr. Derek DiRocco, PhD
  • Independent Director
  • 72.53K
  • Michael A. Sherman, M.B.A.
  • Independent Director
  • 78.66K
  • Dr. Meeta Chatterjee, PhD
  • Independent Director
  • 65.36K
  • Dr. Alon Lazarus, PhD
  • Independent Director
  • 78.53K

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Unlock Now

Discussing

Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina Show More